PTBP1 and Parkinson disease: In a PD mouse model, shRNAs were utilised to knock down polypyrimidine tract binding protein 1 (PTBP1), and transformed astrocytes to dopaminergic neurons, correcting motor impairments and replacing dopaminergic cell loss (Qian et al., 2020).